These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 33218413)

  • 1. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.
    Scarneciu I; Bungau S; Lupu AM; Scarneciu CC; Bratu OG; Martha O; Tit DM; Aleya L; Lupu S
    Eur J Pharm Sci; 2019 Nov; 139():105067. PubMed ID: 31499170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.
    Guo C; Yang B; Gu W; Peng B; Xia S; Yang F; Wen D; Geng J; Zhang Y; Zheng J
    PLoS One; 2013; 8(12):e82591. PubMed ID: 24376550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2013 Sep; 67(9):863-9. PubMed ID: 23952465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review.
    Soliman A; Adel M; Elnagar MA; Elsonbaty S; Hefnawy AE
    Int Urogynecol J; 2024 Sep; 35(9):1735-1743. PubMed ID: 38958727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
    Wang J; Wang Q; Wu Q; Chen Y; Wu P
    Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis.
    Porru D; Leva F; Parmigiani A; Barletta D; Choussos D; Gardella B; Daccò MD; Nappi RE; Allegri M; Tinelli C; Bianchi CM; Spinillo A; Rovereto B
    Int Urogynecol J; 2012 Sep; 23(9):1193-9. PubMed ID: 21904840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
    Jiang YH; Liu HT; Kuo HC
    PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.